![Epwin Group Plc](/common/images/company/L_EPWN.png)
MORRISTOWN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and...
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBCPrecedent-setting submission includes data from post-marketing studies COBALT and Study 401...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3 | -3.20855614973 | 93.5 | 93.5 | 87 | 251778 | 91.28822216 | DE |
4 | 5.5 | 6.47058823529 | 85 | 95 | 85 | 174969 | 90.98715346 | DE |
12 | -1.5 | -1.63043478261 | 92 | 96 | 82.5 | 183465 | 89.34513793 | DE |
26 | 12.5 | 16.0256410256 | 78 | 96 | 75 | 175308 | 85.84962772 | DE |
52 | 20.5 | 29.2857142857 | 70 | 96 | 63 | 149338 | 81.07998375 | DE |
156 | -24 | -20.96069869 | 114.5 | 121 | 63 | 115592 | 82.74628584 | DE |
260 | 18.9 | 26.3966480447 | 71.6 | 121 | 58 | 129583 | 82.75792152 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.